LoDoCo2 Low Dose Colchicine for secondary prevention in Stable Coronary Heart Disease (the LoDoCo2 Trial)

  • Thompson, Peter (Chief Investigator)
  • Nidorf, Stefan (Chief Investigator)
  • Eikelboom, John (Chief Investigator)
StatusActive
Effective start/end date1/01/1531/12/19

Funding

  • National Health & Medical Research Council NHMRC